The best way to predict the future is to invent it.
— Abraham Lincoln
Elpiscience is an immunology-driven company that develops cutting-edge immunotherapies to fight cancer. Science-focused, Elpiscience is led by a team of top-notch executives whose diverse experiences span from managing global pharma strategy to establishing biotech companies in China. Capitalizing on regional strength and global partnerships, Elpiscience has developed a pipeline of over 10 innovative molecules including two IND filing ready assets targeting novel pathways in cancer immunotherapies.